News Conference News EAS 2020 Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention Michael O'Riordan October 08, 2020
News Daily News VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks Michael O'Riordan September 24, 2020
News Conference News ESC 2020 EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF Michael O'Riordan August 28, 2020
News Daily News New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts Michael O'Riordan August 06, 2020
News Daily News Rural-Urban Gap Widens for Cardiometabolic Health Disparities Michael O'Riordan June 22, 2020
News Features COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention Michael O'Riordan April 24, 2020
News Daily News Adherence to Healthy Habits Linked to Years Free of Chronic Disease Michael O'Riordan April 08, 2020
News Daily News Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease Michael O'Riordan March 13, 2020
News Daily News Nearly Half of Diabetic Patients Struggle to Pay Medical Bills Michael O'Riordan February 12, 2020
News Daily News Meat Consumption Linked to Small Rises in CVD, All-Cause Mortality Risks Michael O'Riordan February 05, 2020
News Daily News Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication Michael O'Riordan January 17, 2020
News Daily News Most Secondary Prevention Patients Are Eligible for Multiple Drugs Michael O'Riordan January 03, 2020
News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Daily News Lipid Levels Declining in US, With Drops Seen After 2013 Guideline Release Michael O'Riordan November 11, 2019
News Daily News Obesity Prevalence Triples in China Over 10-Year Span Michael O'Riordan October 28, 2019
News Daily News New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients Michael O'Riordan October 22, 2019
News Conference News ESC 2019 New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL Michael O'Riordan September 05, 2019
News Conference News ESC 2019 New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises Michael O'Riordan September 04, 2019
News Conference News ESC 2019 Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS Michael O'Riordan September 01, 2019